These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23835755)

  • 41. Ocular comfort of combination glaucoma therapies: brimonidine 0.2%/timolol 0.5% compared with dorzolamide 2%/timolol 0.5%.
    Chan K; Testa M; McCluskey P
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):372-6. PubMed ID: 17803436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine Study Group.
    Katz LJ
    Am J Ophthalmol; 1999 Jan; 127(1):20-6. PubMed ID: 9932994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brimonidine Purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension.
    Netland PA; Michael M; Rosner SA; Katzman B; Macy JI
    Adv Ther; 2003; 20(1):20-30. PubMed ID: 12772815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of efficacy and tolerability between two gel-forming timolol maleate ophthalmic solutions in patients with glaucoma or ocular hypertension.
    Shibuya T; Kashiwagi K; Tsukahara S
    Ophthalmologica; 2003; 217(1):31-8. PubMed ID: 12566870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy.
    Konstas AG; Holló G; Haidich AB; Mikropoulos DG; Giannopoulos T; Voudouragkaki IC; Paschalinou E; Konidaris V; Samples JR
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):652-7. PubMed ID: 23550916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brimonidine/Timolol: a viewpoint by Robert M. Feldman.
    Feldman RM
    Drugs Aging; 2006; 23(9):762-3. PubMed ID: 17020401
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5% timolol in normal-tension glaucoma patients.
    Kim JM; Kim TW; Kim CY; Kim HK; Park KH
    Jpn J Ophthalmol; 2016 Jan; 60(1):20-6. PubMed ID: 26578422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The short-term effect of adding brimonidine 0.2% to timolol treatment in patients with open-angle glaucoma.
    Yüksel N; Altintaş O; Karabaş L; Alp B; Cağlar Y
    Ophthalmologica; 1999; 213(4):228-33. PubMed ID: 10420106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Latanoprost topical ophthalmic combinations].
    Călugăru M; Călugăru D
    Oftalmologia; 2004; 48(4):18-28. PubMed ID: 15782758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brimonidine and latanoprost as adjunctive therapy.
    Camras CB
    Ophthalmology; 2004 Feb; 111(2):410-1. PubMed ID: 15019405
    [No Abstract]   [Full Text] [Related]  

  • 53. A double-masked randomized crossover study comparing the effect of latanoprost/timolol and brimonidine/timolol fixed combination on intraocular pressure and ocular blood flow in patients with primary open-angle glaucoma or ocular hypertension.
    Hommer A; Sperl P; Resch H; Popa-Cherecheanu A; Qiao C; Schmetterer L; Garhöfer G
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):569-75. PubMed ID: 22775229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension.
    Hughes BA; Bacharach J; Craven ER; Kaback MB; Mallick S; Landry TA; Bergamini MV
    J Glaucoma; 2005 Oct; 14(5):392-9. PubMed ID: 16148589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of latanoprost, brimonidine and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension.
    Orzalesi N; Rossetti I; Bottoli A; Invernizzi T; Fumagalli E; Fogagnolo P
    Acta Ophthalmol Scand Suppl; 2002; 236():55. PubMed ID: 12390144
    [No Abstract]   [Full Text] [Related]  

  • 56. Modern alchemy: fixed combinations of glaucoma drugs.
    Katz LJ
    Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653
    [No Abstract]   [Full Text] [Related]  

  • 57. Real-life experience of using brinzolamide/brimonidine fixed drop combination in a tertiary glaucoma centre.
    Kóthy P; Holló G
    Int Ophthalmol; 2020 Feb; 40(2):377-383. PubMed ID: 31650353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial.
    Baiza-Durán LM; Alvarez-Delgado J; Contreras-Rubio AY; Medrano-Palafox J; De Luca-Brown A; Casab-Rueda H; Cortés-Gastélum MA; Garcidueñas-Mejía MJ; Gómez-Bastar P; Gil-Carrasco F; Hartleben-Matkin C; Jiménez-Román J; Moreno-Marín ML; Paczka-Zapata JA; Velasco-Gallegos G; Vergara-Sinta M
    Ann Ophthalmol (Skokie); 2009; 41(3-4):174-8. PubMed ID: 20214051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Phase III clinical trial of brimonidine in patients with primary open-angle glaucoma and ocular hypertension--comparison of the effects of brimonidine monotherapy versus timolol monotherapy, or combination brimonidine/prostaglandins therapy versus combination placebo/prostaglandins therapy].
    Araie M; Yamazaki Y; Sugiyama K; Kuwayama Y; Tanihara H
    Nippon Ganka Gakkai Zasshi; 2012 Oct; 116(10):955-66. PubMed ID: 23285843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.